PDE5A and neoplasm: A study on immunosuppressive mechanisms focusing on CIKs found that combination treatment with a PDE5 inhibitor reversed the MDSC suppressor function via arginase-1 and iNOS blockade and systemic treatment with a PDE5 inhibitor prevented MDSC accumulation in the TME of the tumor bearing mice (135).